These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33359359)

  • 1. Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency.
    Shafer S; Yao Y; Comrie W; Cook S; Zhang Y; Yesil G; Karakoç-Aydiner E; Baris S; Cokugras H; Aydemir S; Kiykim A; Ozen A; Lenardo M
    J Allergy Clin Immunol; 2021 Jul; 148(1):256-261.e2. PubMed ID: 33359359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis.
    Marujo F; Pelham SJ; Freixo J; Cordeiro AI; Martins C; Casanova JL; Lei WT; Puel A; Neves JF
    J Clin Immunol; 2021 Aug; 41(6):1376-1379. PubMed ID: 33825088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2.
    Bhattad S; Dinakar C; Pinnamaraju H; Ganapathy A; Mannan A
    J Clin Immunol; 2019 Aug; 39(6):596-599. PubMed ID: 31292894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.
    Blanco Lobo P; Lei WT; Pelham SJ; Guisado Hernández P; Villaoslada I; de Felipe B; Lucena JM; Casanova JL; Olbrich P; Puel A; Neth O
    Pediatr Allergy Immunol; 2021 Nov; 32(8):1804-1812. PubMed ID: 34289170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.
    Boisson B; Wang C; Pedergnana V; Wu L; Cypowyj S; Rybojad M; Belkadi A; Picard C; Abel L; Fieschi C; Puel A; Li X; Casanova JL
    Immunity; 2013 Oct; 39(4):676-86. PubMed ID: 24120361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.
    Alves de Medeiros AK; Lodewick E; Bogaert DJ; Haerynck F; Van Daele S; Lambrecht B; Bosma S; Vanderdonckt L; Lortholary O; Migaud M; Casanova JL; Puel A; Lanternier F; Lambert J; Brochez L; Dullaers M
    J Clin Immunol; 2016 Apr; 36(3):204-9. PubMed ID: 26961233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis.
    Ling Y; Cypowyj S; Aytekin C; Galicchio M; Camcioglu Y; Nepesov S; Ikinciogullari A; Dogu F; Belkadi A; Levy R; Migaud M; Boisson B; Bolze A; Itan Y; Goudin N; Cottineau J; Picard C; Abel L; Bustamante J; Casanova JL; Puel A
    J Exp Med; 2015 May; 212(5):619-31. PubMed ID: 25918342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
    Fellmann F; Angelini F; Wassenberg J; Perreau M; Arenas Ramirez N; Simon G; Boyman O; Demaria O; Christen-Zaech S; Hohl D; Belfiore M; von Scheven-Gete A; Gilliet M; Bochud PY; Perrin Y; Beck Popovic M; Bart PA; Beckmann JS; Martinet D; Hofer M
    J Allergy Clin Immunol; 2016 Apr; 137(4):1189-1196.e2. PubMed ID: 26607704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
    Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
    Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
    Puel A; Cypowyj S; Bustamante J; Wright JF; Liu L; Lim HK; Migaud M; Israel L; Chrabieh M; Audry M; Gumbleton M; Toulon A; Bodemer C; El-Baghdadi J; Whitters M; Paradis T; Brooks J; Collins M; Wolfman NM; Al-Muhsen S; Galicchio M; Abel L; Picard C; Casanova JL
    Science; 2011 Apr; 332(6025):65-8. PubMed ID: 21350122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CMCD: Chronic Mucocutaneous Candidiasis Disease].
    Okada S
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):109-117. PubMed ID: 28603201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous CARD9 mutation in a family with susceptibility to fungal infections.
    Glocker EO; Hennigs A; Nabavi M; Schäffer AA; Woellner C; Salzer U; Pfeifer D; Veelken H; Warnatz K; Tahami F; Jamal S; Manguiat A; Rezaei N; Amirzargar AA; Plebani A; Hannesschläger N; Gross O; Ruland J; Grimbacher B
    N Engl J Med; 2009 Oct; 361(18):1727-35. PubMed ID: 19864672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.
    Huppler AR; Bishu S; Gaffen SL
    Arthritis Res Ther; 2012 Jul; 14(4):217. PubMed ID: 22838497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated Chronic Mucocutaneous Candidiasis due to a Novel Duplication Variant of IL17RC.
    Noma K; Tsumura M; Nguyen T; Asano T; Sakura F; Tamaura M; Imanaka Y; Mizoguchi Y; Karakawa S; Hayakawa S; Shoji T; Hosokawa J; Izawa K; Ling Y; Casanova JL; Puel A; Tangye SG; Ma CS; Ohara O; Okada S
    J Clin Immunol; 2023 Dec; 44(1):18. PubMed ID: 38129603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections].
    Baghad B; Benhsaien I; El Fatoiki FZ; Migaud M; Puel A; Chiheb S; Bousfiha AA; Ailal F
    Ann Dermatol Venereol; 2020 Jan; 147(1):41-45. PubMed ID: 31677808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.
    Soltész B; Tóth B; Sarkadi AK; Erdős M; Maródi L
    Int Rev Immunol; 2015; 34(4):348-63. PubMed ID: 26154078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
    Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
    Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
    Soltész B; Tóth B; Shabashova N; Bondarenko A; Okada S; Cypowyj S; Abhyankar A; Csorba G; Taskó S; Sarkadi AK; Méhes L; Rozsíval P; Neumann D; Chernyshova L; Tulassay Z; Puel A; Casanova JL; Sediva A; Litzman J; Maródi L
    J Med Genet; 2013 Sep; 50(9):567-78. PubMed ID: 23709754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
    Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
    J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human dectin-1 deficiency and mucocutaneous fungal infections.
    Ferwerda B; Ferwerda G; Plantinga TS; Willment JA; van Spriel AB; Venselaar H; Elbers CC; Johnson MD; Cambi A; Huysamen C; Jacobs L; Jansen T; Verheijen K; Masthoff L; Morré SA; Vriend G; Williams DL; Perfect JR; Joosten LA; Wijmenga C; van der Meer JW; Adema GJ; Kullberg BJ; Brown GD; Netea MG
    N Engl J Med; 2009 Oct; 361(18):1760-7. PubMed ID: 19864674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.